10:24 AM EDT, 03/21/2024 (MT Newswires) -- Benjamin T Dake, President, Chief Operating Officer and Secretary, on March 18, 2024, sold 35,057 shares in Aerovate Therapeutics ( AVTE ) for $908,046. Following the Form 4 filing with the SEC, Dake has control over a total of 1,291 shares of the company, with 1,291 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1798749/000141588924008770/xslF345X03/form4-03202024_060307.xml

Price: 26.18, Change: +0.29, Percent Change: +1.12